Mathai Mammen

Mathai Mammen

Directeur Général chez PARABILIS MEDICINES, INC.

Fortune : 511 971 $ au 31/05/2026

59 ans
Health Technology
Finance
Consumer Services

Profil

Mathai Mammen was the founder of Innoviva, Inc., founded in 1996, where the title held was Senior VP-Research & Early Clinical Development from 2011 to 2014.
Dr. Mammen was the founder of Theravance Biopharma, Inc., founded in 1997, where the title held was Senior Vice President-Research & Development from 2014 to 2016.
Current jobs include Chairman, President & Chief Executive Officer at Parabilis Medicines, Inc. since 2023; Director at Kelonia Therapeutics, Inc.; Director at MIT Jameel Clinic; Independent Director at Sandoz Group AG since 2024; Advisor at Foresite Capital Management LLC since 2019; and Senior Advisor at General Atlantic LLC.
Former jobs include Independent Director at 10X Genomics, Inc. from 2017 to 2024; Senior Vice President at Merck Research Laboratories Massachusetts LLC from 2016 to 2017; Global Head-Research & Development at Janssen Research & Development LLC from 2017 to 2022; EVP-Pharmaceuticals, Research & Development at Johnson & Johnson in 2022; Vice President at American Society for Microbiology; and Senior Vice President at Merck & Co., Inc. from 2016 to 2017.
Education includes doctorate degrees from Harvard Medical School, Massachusetts Institute of Technology, and Harvard University, and an undergraduate degree from Dalhousie University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/12/2025 6 098 ( 0 % ) 511 971 $ 31/05/2026
10/06/2026 0 ( -.--% ) - $ 31/05/2026

Dernières actualités sur Mathai Mammen

Postes actifs de Mathai Mammen

SociétésPosteDébut
PARABILIS MEDICINES, INC. Directeur Général 30/06/2023
SANDOZ GROUP AG Directeur/Membre du Conseil 30/04/2024
Consultant / Advisor -
Consultant / Advisor 01/01/2019
MIT Jameel Clinic
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -

Anciens postes connus de Mathai Mammen

SociétésPosteFin
10X GENOMICS, INC. Directeur/Membre du Conseil 24/10/2024
JOHNSON & JOHNSON Directeur Technique/Scientifique/R&D 08/08/2022
Corporate Officer/Principal 01/01/2022
░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Mathai Mammen

Formation de Mathai Mammen

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

47

Relations au 1er degré

18

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées18

Health Technology

Health Technology

Finance

Health Technology

Consumer Services

Health Technology

Finance

Consumer Services

Health Technology

Commercial Services

Consumer Services

Finance

Commercial Services

Health Technology

Health Technology

MIT Jameel Clinic

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Mathai Mammen
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇